NCT05087212View on ClinicalTrials.gov

Mobilization of Stem Cells With AMD3100 (Plerixafor) in Combination With G-CSF in Multiple Myeloma Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

October 22, 2021

Primary Completion Date

December 6, 2022

Study Completion Date

December 30, 2022

Conditions
Autologous Haematopoietic Stem Cell Transplant
Interventions
DRUG

plerixafor + G-CSF

subcutaneous (SC) injection

Trial Locations (1)

Unknown

Investigational Sites, China

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY